However just to add, the fact that even though it might work on Hep C, but is much more expensive that current treatments is not particular relevant at the moment. It's the mode of efficacy that is important. The fact that BIT's drugs target the E protein on the wall of the virus, inhibiting it's ability to move in and out of cells and replicate, and the fact that lot's of viruses have this E protein is what makes BIT's drugs exciting because they can be pan-effect, meaning that even if a virus mutates, they will still work. With vaccines, a new one has to be developed every time a virus mutates, so this gives BIT an advantage over vaccines because they can inhibit an infection until the body's own immune system kicks in and start producing antibodies against the pathogen..
BIT Price at posting:
12.0¢ Sentiment: Hold Disclosure: Held
